Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjögren's syndrome

Mod Rheumatol. 2013 Mar;23(2):401-5. doi: 10.1007/s10165-012-0667-0. Epub 2012 Jun 28.

Abstract

A 62-year-old woman was diagnosed with severe osteomalacia caused by renal tubular acidosis associated with Sjögren's syndrome. She was treated with sodium bicarbonate, risedronate, alfacalcidol, and prednisolone (1 mg/kg). By 24 months, renal tubular acidosis was improved and the bone density had normalized. Here we report the successful amelioration of bone lesions through a multidisciplinary approach that improved renal tubular acidosis, with a special focus on treatment of the underlying inflammatory disorder with glucocorticoids.

Publication types

  • Case Reports

MeSH terms

  • Acidosis, Renal Tubular / complications*
  • Bone Density Conservation Agents / therapeutic use*
  • Drug Therapy, Combination
  • Etidronic Acid / analogs & derivatives
  • Etidronic Acid / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Hydroxycholecalciferols / therapeutic use
  • Middle Aged
  • Osteomalacia / drug therapy*
  • Osteomalacia / etiology
  • Prednisolone / therapeutic use
  • Risedronic Acid
  • Sjogren's Syndrome / complications*
  • Sodium Bicarbonate / therapeutic use
  • Treatment Outcome

Substances

  • Bone Density Conservation Agents
  • Glucocorticoids
  • Hydroxycholecalciferols
  • Sodium Bicarbonate
  • Prednisolone
  • Risedronic Acid
  • Etidronic Acid
  • alfacalcidol